Elvanse / Vyvanse Crash: When It Hits and Why (With a Timing Chart)
The Vyvanse label puts the peak about 4 hours after the dose. See the typical curve, what people describe when it wears off, and what to tell your prescriber.
Typical Vyvanse curve
Population average for a dose at 8am. Yours will differ, and that gap is what logging shows.
Get new titration guides by email
Occasional, evidence-based guides on medication tracking and titration — no noise.
Disclaimer: This article is for educational purposes only. It does not constitute medical advice, diagnosis, or a prescription recommendation. All medication decisions must be made by you and your licensed healthcare provider based on your individual medical history and circumstances.
Vyvanse (US and Israel) and Elvanse (UK) are the same medication: lisdexamfetamine, an amphetamine prodrug. It is a long-acting ADHD stimulant: in the adult workplace study in its US label, it still beat placebo 14 hours after the dose [1]. For many adults, that means a single daily dose that covers the full workday.
But Vyvanse/Elvanse is not crash-proof. The afternoon decline (a gradual return of ADHD symptoms, lower energy, irritability, or a sudden appetite surge) is something many people describe. This guide explains the duration curve, what the afternoon crash actually is, how to tell it from normal tiredness, and what to log so your prescriber can act on it.
What is Vyvanse / Elvanse?
Lisdexamfetamine is a prodrug: the capsule contains an inactive molecule (lisdexamfetamine dimesylate) that is converted, mainly by red blood cells, into the active drug, dextroamphetamine. That conversion step sets the pace at which the active drug reaches the body, which helps explain Vyvanse's gradual rise and long effect [1][2].
The conversion happens mostly in the blood rather than through liver enzymes, and in the label a high-fat meal, yogurt or orange juice did not change the total amount of drug absorbed from the capsule [1].
Brand names by market
| Market | Brand name | Notes |
|---|---|---|
| United States | Vyvanse | 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg capsules; also chewable tablets |
| UK / Ireland | Elvanse | Same molecule, different branding |
| Israel | Vyvanse | Sold under the Vyvanse name (ויואנס) |
People often search for both Vyvanse and Elvanse in English, especially if they have moved between countries. This guide uses both names interchangeably.
Vyvanse / Elvanse dosing and titration
Vyvanse / Elvanse comes in a range of capsule strengths, plus chewable tablets in some markets. Your prescriber chooses the starting dose, how quickly to move, and where to stop. Titrate does not recommend doses. Children and adolescents are dosed differently from adults.
| Phase | What you might notice | What to log |
|---|---|---|
| Week 1 | Tolerability check; effect may be subtle | Dose time, appetite, sleep |
| Week 2 | Some adults start noticing clearer benefit | Focus, wear-off time, side effects |
| Week 3+ | The overall pattern becomes clear | Afternoon crash timing, sleep, function |
The Vyvanse / Elvanse duration curve
Vyvanse does not peak sharply. Most adults describe the experience as a gradual ramp-up, a long plateau, and a gradual decline. In the label's adult workplace study, it beat placebo at every time point measured, from 2 hours through 14 hours after the dose. In the children's study, the benefit was significant from 2 to 12 hours but not yet at 1 hour [1].
| Time after dose | Phase | Typical experience |
|---|---|---|
| 0–1.5 hours | Onset | Subtle; some people feel nothing yet |
| 1.5–4 hours | Rising effect | Focus and motivation improve; blood levels peak around 3.8 hours in fasted adults |
| 4–8 hours | Peak / plateau | Strongest symptom control for many people |
| 8–12 hours | Gradual decline | Effect tapers; some notice rebound |
| 12+ hours | Wear-off | ADHD symptoms return; sleep can suffer if the dose was late |
Food changes the timing a little but not the amount. In the label, a high-fat meal pushed the peak from about 3.8 hours to about 4.7 hours, roughly an hour later, without changing total absorption [1]. Taking it the same way each day keeps your curve easier to read.
What is the afternoon crash?
The "afternoon crash" on Vyvanse/Elvanse is usually one of two things, and telling them apart changes the conversation with your prescriber.
1. Pharmacokinetic decline (the real medication wear-off)
Amphetamine works by increasing dopamine and norepinephrine activity in the brain [5]. As the active drug is cleared, that effect fades. For some adults, the decline produces a noticeable dip in focus, energy, or mood 8–12 hours after dosing. This is a rebound-like return of ADHD symptoms as coverage drops.
Common signs:
- Return of distractibility and impulsivity
- Lower energy, mental fatigue
- Irritability or emotional sensitivity
- Sudden appetite increase
- Difficulty completing evening tasks
2. Normal circadian dip amplified by stimulant timing
Many people have a natural dip in alertness in the mid-afternoon, linked to a rise in sleepiness at that time of day, and it can happen even when you skip lunch [3]. Stimulants can mask this dip early in the day and then make the contrast feel sharper when coverage falls. This may not be a "crash" at all; it may be the normal afternoon slump that the medication had been covering.
The difference matters because the conversations are different: a true wear-off is something to raise with your prescriber, while a normal afternoon dip may respond to a short walk, a snack, or changes to how you schedule your tasks.
Why the Elvanse crash can come after 5 hours
An Elvanse (Vyvanse) crash after only 4–6 hours comes earlier than the drug's measured effect: in the adult workplace study in the FDA label, lisdexamfetamine still beat placebo at every time point from 2 to 14 hours after the dose [1].
Blood levels of dextroamphetamine, the active drug, peak about 3.8 hours after a fasted dose and about 4.7 hours after a high-fat meal, then fall slowly, with a half-life of roughly 10–11 hours in healthy adults [1]. At hour 5 most of the drug is still on board. So when a crash hits that early, it is worth looking at other causes before assuming the medication simply ran out:
- The first slide after the peak. Some people feel the change in level more than the level itself, so the first drop after the peak can feel like a crash.
- A dose that only works at the peak. If focus is clearly there around hours 3–5 and gone soon after, the dose may be below what you need for the full day. That is a question for your prescriber, not something to fix with extra capsules.
- The day around the dose. A skipped breakfast or lunch, a caffeine wear-off, or a short night's sleep can all feel like the medication stopped.
What helps your prescriber most is the clock: the time you took the dose, what you ate, the time the crash started and how bad it was. Three or four days of that usually shows whether the early crash is the drug, the dose, or the day.
Elvanse crash and anxiety
Anxiety is a listed side effect of Vyvanse / Elvanse itself: in a 4-week adult trial, 6% of people taking it reported anxiety, against 0% on placebo [1].
That means anxiety on Elvanse can come from two different places:
- While the medication is working. Feeling tense, jittery or on edge while focus is good points to a side effect of the dose.
- As it wears off. Irritability, low mood or a restless, anxious feeling later in the day fits the wear-off pattern described above.
The timing is what tells them apart, so log when the anxiety starts, not just that it happened. Anxiety that is severe, comes with chest pain or a racing heart that won't settle, or turns into panic needs a call to your prescriber or urgent care the same day.
What to log during Vyvanse / Elvanse titration
Logging is the only way to separate a real medication issue from a normal day. During the first 3–4 weeks, track at least these three time points:
| Time after dose | What to log |
|---|---|
| 1.5 hours | Focus, motivation, any anxiety or jitteriness |
| 4–6 hours | Peak effect, productivity, appetite, mood |
| 8–12 hours | Afternoon decline, rebound symptoms, mood, sleep readiness |
At each point, rate:
- Focus (1–5)
- Energy/motivation (1–5)
- Irritability or anxiety (1–5)
- Appetite (1–5)
Also log:
- Dose time, because consistency matters
- Food: did you take it with or without food?
- Sleep: time to fall asleep, total hours, quality
- Caffeine: amount and timing, since caffeine is a stimulant too
Patterns that matter for your prescriber
The data is only useful if it reveals patterns. These are the patterns that most often prompt a conversation about the plan. What to change, if anything, is your prescriber's call.
| Pattern you log | Possible explanation | Question to bring |
|---|---|---|
| Focus fades 4–6 hours after the dose, every day | The first drop after the peak, or a dose that only covers the peak | "Is my coverage the issue, or the dose?" |
| Crash 8–12 hours after the dose, with symptoms coming back | The normal end of the medication's effect | "Is there a way to cover the early evening?" |
| Dip around mid-afternoon, worse after short sleep or a skipped meal | A normal afternoon dip, or the day around the dose | "Does this look like the medication or my day?" |
| Tense or jittery while focus is good | A side effect of the dose itself | "Is this anxiety something we should act on?" |
| Trouble falling asleep most nights | The effect still running at bedtime | "Would a different dose time help my sleep?" |
Managing the afternoon crash day to day
While you gather data for your prescriber, a few things are worth trying or asking about:
- Ask about dose timing. The label says to take it in the morning and avoid afternoon doses because of the potential for insomnia [1]. Keep your dose time consistent and log it.
- Notice what you ate. Log breakfast and lunch on crash days. NICE suggests eating with or after the dose, and planning meals for when the stimulant effect has worn off, if weight loss becomes a concern [4].
- Notice drink and rest. Log water, sleep and breaks, so you can see whether the crash is worse on days when those slip.
- Plan lighter tasks for the decline phase if your schedule allows, and note whether that makes the evening easier.
- Log caffeine. It is a stimulant too, so tell your prescriber how much you drink and when.
- Track for 2–3 weeks. Patterns are more reliable than single-day impressions.
When to raise it with your prescriber
Talk to your prescriber if:
- The afternoon crash is functionally impairing (you can't parent, work, or drive safely)
- The crash is getting worse after a change to your plan
- You need coverage beyond 12 hours
- Sleep onset is consistently delayed by 2+ hours
- Anxiety or irritability during the peak is significant
- Appetite suppression is affecting nutrition or weight
Your prescriber may consider options such as a dose adjustment, timing adjustment, switching to a different formulation, adding a short-acting dose later in the day, or a non-stimulant.
Track your Vyvanse / Elvanse curve with Titrate
The afternoon crash is one of the most under-reported parts of ADHD stimulant treatment because it happens after the workday, when most people aren't thinking about their medication. But it's often the most important signal for whether the dose, timing, or formulation is right.
Titrate makes this easy: daily check-ins at the times that matter, a structured effect curve, and a shareable report that shows your prescriber exactly when your coverage rises, peaks, and falls, not just what you remember from the morning of your appointment.
→ Start tracking your Vyvanse / Elvanse curve free ← → See how prescribers view Titrate reports ←
Also see our guides on Concerta titration, stimulant titration timelines, and ADHD medication and sleep.
FAQ
Q: How long does Vyvanse / Elvanse last? In the label's adult workplace study, Vyvanse beat placebo at every time point from 2 to 14 hours after the dose; in children, from 2 to 12 hours. How long it feels like it lasts varies from person to person, so logging your own wear-off time is the most useful thing to bring to your prescriber.
Q: Can I take Vyvanse / Elvanse later on weekends? The label says to take it in the morning and to avoid afternoon doses because of the potential for insomnia. If you sleep in on weekends, ask your prescriber what they want you to do on those days, and log the dose time so you can see the effect on your sleep.
Q: Does food change how Vyvanse / Elvanse works? Food doesn't change how much of the drug you absorb, but in the label a high-fat meal pushed the peak back by about an hour (from about 3.8 to 4.7 hours). The key is consistency: take it the same way each day so your curve is predictable.
Q: Why does my Elvanse / Vyvanse crash after 5 hours? The active drug peaks about 4 to 5 hours after the dose and then falls slowly, with a half-life of about 10–11 hours in adults, so at hour 5 most of it is still on board. An early crash is more often the first drop after the peak, a dose that only works at the peak, or a skipped meal, caffeine wear-off or short sleep. Log the timing for a few days and bring it to your prescriber.
Q: Can Elvanse / Vyvanse cause anxiety? Yes. Anxiety is a listed side effect: 6% of adults in a 4-week trial reported it, against 0% on placebo. Anxiety while the medication is working points to a side effect; irritability or anxious feelings late in the day fit the wear-off. Log when it starts, and call your prescriber the same day if it is severe or comes with chest pain or a racing heart.
Q: Is the afternoon crash a sign the dose is too low? Not necessarily. A crash can mean your current plan needs a look, or simply that the medication is wearing off at the end of its normal duration. Logging the timing and severity of the crash is what helps your prescriber decide.
Q: Can I take a second dose of Vyvanse / Elvanse in the afternoon? Not unless your prescriber has told you to. The label describes Vyvanse as a once-daily morning dose and says to avoid afternoon doses because of the potential for insomnia. If the evening is a problem, bring your log to your prescriber and ask what options there are.
Q: Why does Vyvanse feel smoother than Adderall XR? Vyvanse is a prodrug that is converted into the active drug in the blood, and that conversion sets the pace at which the active drug appears. Adderall XR uses two kinds of beads, one released right away and one delayed. Individual response varies.
Q: Is generic Vyvanse the same as brand-name? It has the same active ingredient. If you notice a change in onset, duration or side effects after a pharmacy switch, log the date and what changed, and tell your prescriber.
Key takeaways
- Vyvanse and Elvanse are the same medication, lisdexamfetamine, with different brand names in different markets.
- The prodrug design gives a gradual rise and a long effect: in the label's adult study it beat placebo from 2 to 14 hours after the dose.
- The "afternoon crash" is often a mix of medication wear-off and a normal afternoon dip, and logging tells them apart.
- Track at 1.5 hours, 4–6 hours, and 8–12 hours after dosing to see your full curve.
- Timing, food, caffeine, and sleep all affect what you feel, so consistency makes the data useful.
- A crash that impairs evening function is a clinical signal, not something to ignore.
- Titrate turns daily logging into a shareable report your prescriber can use to adjust dose or timing.
References
- Vyvanse (lisdexamfetamine dimesylate) — FDA Prescribing Information (current label). Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad
- Pennick M. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010;6:317-327. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC2898170/
- Monk TH. The post-lunch dip in performance. Clin Sports Med. 2005;24(2):e15-23. Available at: https://pubmed.ncbi.nlm.nih.gov/15892914/
- NICE Guideline NG87 — Attention deficit hyperactivity disorder: diagnosis and management (2018, last updated 2019). Recommendation 1.8.6. Available at: https://www.nice.org.uk/guidance/ng87/chapter/Recommendations
- Faraone SV. The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018;87:255-270. Available at: https://pubmed.ncbi.nlm.nih.gov/29428394/
This article is for educational purposes only. It does not constitute medical advice. Always consult your licensed healthcare provider about medication decisions.